Human metapneumovirus driven IFN-β production antagonizes macrophage transcriptional induction of IL1-β in response

Simon Loevenich1,2, Nicola P Montaldo1, Arthur Wickenhagen1,3

  • 1Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.

PubMed

Insights

Human metapneumovirus (HMPV) infection suppresses IL-1β production in macrophages, increasing bacterial superinfection risk. This occurs via epigenetic changes at the IL1B promoter, mediated by TBK1 and type I interferon signaling.

Area of Science:

  • Immunology
  • Virology
  • Molecular Biology

Background:

  • Human metapneumovirus (HMPV) exacerbates bacterial superinfections, increasing respiratory disease severity.
  • Type I interferons (IFNs) can dysregulate immune responses during viral infections.
  • Mechanisms of HMPV-induced susceptibility to bacterial infections are not well understood.

Purpose of the Study:

  • Investigate how HMPV pre-infection alters human macrophage inflammatory responses to bacterial stimuli.
  • Elucidate the molecular pathways involved in HMPV-mediated cytokine dysregulation.

Main Methods:

  • Human macrophages were pre-infected with HMPV, then stimulated with LPS or heat-killed bacteria.
  • Cytokine mRNA levels (IL-1β, IL-6, TNF-α, IFN-β) were quantified.
  • NF-κB and HIF-1α activation, TBK1, IFNAR signaling, and H3K27me3 epigenetic marks at the IL1B promoter were analyzed.

Main Results:

  • HMPV pre-infection suppressed IL-1β transcription but enhanced IL-6, TNF-α, and IFN-β mRNA in response to bacterial stimuli.
  • Suppression of IL-1β required TBK1 and IFN-β-IFNAR signaling.
  • NF-κB and HIF-1α activation remained intact.
  • HMPV-LPS sequential treatment led to H3K27me3 accumulation at the IL1B promoter.

Conclusions:

  • HMPV epigenetically reprograms human macrophages to suppress IL-1β production, potentially increasing susceptibility to bacterial superinfections.
  • This mechanism involves TBK1, type I IFN signaling, and epigenetic modification of the IL1B promoter.
  • Findings offer insights into viral-bacterial interactions in respiratory diseases.